Risecomm to Capitalise RMB139.10 Million Debt via HK$128.46 Million Zero-Coupon CBs and Place Up to 85.87 Million New Shares

Bulletin Express05-27

Risecomm Group Holdings Limited has entered into five loan-capitalisation agreements and a placing mandate aimed at shoring up its balance sheet and easing near-term liquidity pressure.

Loan Capitalisation • Date: 27 May 2026 • Instruments: – 69.82 million new shares at HK$0.46 each (11.54% discount to last close) – Zero-coupon convertible bonds (CBs) with an aggregate principal of HK$128.46 million, convertible at HK$0.46 into 279.27 million shares within three years. • Purpose: Full settlement of outstanding subscriber loans of approximately RMB139.10 million (about HK$151 million). • Impact: Capitalisation shares equal 32.35% of current share capital; full CB conversion would lift the new shares issued under this exercise to 49.44% of the enlarged base. • Connected parties: Director Guo Lei, senior manager Ning Jun (through Linker Union) and their associates are involved and will abstain from voting at the forthcoming EGM.

Placing of New Shares • Mandate: GEO Securities Limited to place up to 85.87 million shares on a best-effort basis at HK$0.46. • Gross / net proceeds: HK$39.50 million / HK$39.00 million, earmarked for repayment of two remaining unsecured loans (HK$33.20 million from shareholder Fu Xiaoqin and HK$5.80 million from Clear Jolly Holdings). • Dilution: Placing shares represent 39.79% of existing issued shares and 28.46% post-placing.

Combined Equity Effect Assuming full CB conversion and full placing, the company will issue 434.95 million new shares, expanding the share base by 201.54% to 650.77 million shares. The theoretical cumulative dilution, including last year’s five-for-one rights issue, is estimated at 24.86% under Listing Rule 7.27B.

Strategic Rationale Management cites recurring net losses (RMB23.70 million in FY-2025), net current liabilities of RMB18.80 million and total borrowings of RMB179.00 million as key drivers. The capitalisation eliminates high-interest debt (2.5%–12% p.a.) and removes imminent maturities, while the zero-coupon CBs cut future finance costs. The placing proceeds will convert remaining short-term debt into equity, turning net current liabilities into net current assets and improving the gearing ratio.

Timetable and Approvals Both the capitalisation shares, CB conversion shares and placing shares require a specific mandate from independent shareholders at an extraordinary general meeting (EGM). Listing approval from Hong Kong Exchanges and Clearing Limited is also a condition precedent. Neither transaction is inter-conditional, and completion long-stop dates are set at 30 September 2026.

Shareholders and potential investors are advised to exercise caution until the EGM and listing approvals are secured.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment